Chardan Adjusts Price Target on Senti Biosciences to $7 From $8, Keeps Buy Rating
Chardan Adjusts Price Target on Senti Biosciences to $7 From $8, Keeps Buy Rating
夏丹調整森蒂生物科學的價格目標價格從 $7 從 $8，保持購買評級
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊